Azimuth is excited to announce that we have received FDA Emergency Use Authorization for our new, patent-pending, PortPatch™ product! Made of N99-rated filter material , PortPatch™ is intended to reduce the spread of airborne particulates through the exhalation ports, anti-asphyxia valves and carbon dioxide vents on full-face or non-rebreathing CPAP and other ventilation masks.
PortPatch™ allows CPAP and BiPAP to be used more safely in patient-care settings such as hospitals, hospital patient care areas and rooms, long- term care facilities and sleep laboratories. PortPatch™ can also be used by patients on their CPAP masks at home.
PortPatch™ was created to help keep our front-line care providers safer during this pandemic, and to expand treatment options available to their patients.
To learn more or place your order please contact us as email@example.com
We know that using CPAP can be a challenge. We are here to help. Share your thoughts and become a part of the solution to troublesome CPAP treatment options.
We are working on building the future of CPAP mask design. Small, strapless and precision fit to your features. See how interest in our company is growing!
Stay tuned for your first glimpse of our latest device! You're going to love it!